Investor FAQs
Stock Information
Eagle Pharmaceuticals became a publicly traded company on February 12, 2014.
Eagle Pharmaceuticals trades on the Nasdaq stock exchange with the ticker symbol “EGRX”.
A transfer agent is a regulated organization that keeps track of stockholder records and information. Eagle Pharmaceuticals’ transfer agent is American Stock Transfer & Trust Company. Shareholders may contact American Stock Transfer & Trust Company at:
American Stock Transfer & Trust Company
Operations Center
6201 15th Avenue
Brooklyn, NY 11219
Shareholder inquiries: (718) 921-8124
Shareholder services: (800) 937-5449
Email shareholder services
Financial Reporting Information
Eagle Pharmaceuticals’ fiscal year end is December 31st.
All of Eagle Pharmaceuticals’ SEC filings can be found on our SEC filings page, on the SEC's public website at www.sec.gov, and at Edgar® Online®.
Company Information
You may contact Eagle’s Investor Relations firm, In-Site Communications, by phone at (212) 452-2793 or mail investors@eagleus.com.